Françoise

Francoise Argoul, Lyon FR

Patent application number	Description	Published
20100328674	HIGH-RESOLUTION SURFACE PLASMON MICROSCOPE WITH HETERODYNE INTERFEROMETRY IN RADIAL POLARIZATION MODE - The present invention relates to a high-resolution scanning surface-plasmon microscope including a source (LG) of coherent light and a medium for coupling and confining a surface plasmon including an objective (O, O	12-30-2010
20120019907	HIGH-RESOLUTION SURFACE PLASMON MICROSCOPE THAT INCLUDES A HETERODYNE FIBER INTERFEROMETER - The present invention relates to a high-resolution surface plasmon microscope including a heterodyne interferometer (	01-26-2012

Francoise Barre-Sinoussi, Moulimeaux FR

Patent application number	Description	Published
20100184014	Non-M, non-O HIV-1 strains, fragments and uses - Retroviral strains of the non-M, non-O HIV-1 group, in particular a strain designated YBF30, its fragments and also its uses as a diagnostic reagent and as an immunogenic agent.	07-22-2010

Francoise Beaufays, Mountain View, CA US

Patent application number	Description	Published
20100004930	Speech Recognition with Parallel Recognition Tasks - The subject matter of this specification can be embodied in, among other things, a method that includes receiving an audio signal and initiating speech recognition tasks by a plurality of speech recognition systems (SRS's). Each SRS is configured to generate a recognition result specifying possible speech included in the audio signal and a confidence value indicating a confidence in a correctness of the speech result. The method also includes completing a portion of the speech recognition tasks including generating one or more recognition results and one or more confidence values for the one or more recognition results, determining whether the one or more confidence values meets a confidence threshold, aborting a remaining portion of the speech recognition tasks for SRS's that have not completed generating a recognition result, and outputting a final recognition result based on at least one of the generated one or more speech results.	01-07-2010
20110047139	Business Listing Search - A method of operating a voice-enabled business directory search system includes receiving category-business pairs, each category-business pair including a business category and a specific business, and establishing a data structure having nodes based on the category-business pairs. Each node of the data structure is associated with one or more business categories and a speech recognition language model for recognizing specific businesses associated with the one or more businesses categories.	02-24-2011
20110235790	Computing Device With Remote Contact Lists - In one implementation a computer-implemented method includes generating a group of telephone contacts for a first user, wherein the generating includes identifying a second user as a contact of the first user based upon a determination that the second user has at least a threshold email-based association with the first user; and adding the identified second user to the group of telephone contacts for the first user. The method further includes receiving a first request to connect a first telephone device associated with the first user to a second telephone device associated with the second user. The method also includes identifying a contact identifier of the second telephone device using the generated group of telephone contacts for the first user, and initiating a connection between the first telephone device and the second telephone device using the identified contact identifier.	09-29-2011
20120020254	COMPUTING DEVICE WITH REMOTE CONTACT LISTS - In one implementation a computer-implemented method includes generating a group of telephone contacts for a first user, wherein the generating includes identifying a second user as a contact of the first user based upon a determination that the second user has at least a threshold email-based association with the first user; and adding the identified second user to the group of telephone contacts for the first user. The method further includes receiving a first request to connect a first telephone device associated with the first user to a second telephone device associated with the second user. The method also includes identifying a contact identifier of the second telephone device using the generated group of telephone contacts for the first user, and initiating a connection between the first telephone device and the second telephone device using the identified contact identifier.	01-26-2012
20130138440	SPEECH RECOGNITION WITH PARALLEL RECOGNITION TASKS - The subject matter of this specification can be embodied in, among other things, a method that includes receiving an audio signal and initiating speech recognition tasks by a plurality of speech recognition systems (SRS's). Each SRS is configured to generate a recognition result specifying possible speech included in the audio signal and a confidence value indicating a confidence in a correctness of the speech result. The method also includes completing a portion of the speech recognition tasks including generating one or more recognition results and one or more confidence values for the one or more recognition results, determining whether the one or more confidence values meets a confidence threshold, aborting a remaining portion of the speech recognition tasks for SRS's that have not generated a recognition result, and outputting a final recognition result based on at least one of the generated one or more speech results.	05-30-2013
20130238336	RECOGNIZING SPEECH IN MULTIPLE LANGUAGES - Speech recognition systems may perform the following operations: receiving audio; recognizing the audio using language models for different languages to produce recognition candidates for the audio, where the recognition candidates are associated with corresponding recognition scores; identifying a candidate language for the audio; selecting a recognition candidate based on the recognition scores and the candidate language; and outputting data corresponding to the selected recognition candidate as a recognized version of the audio.	09-12-2013
20140058728	Speech Recognition with Parallel Recognition Tasks - The subject matter of this specification can be embodied in, among other things, a method that includes receiving an audio signal and initiating speech recognition tasks by a plurality of speech recognition systems (SRS's). Each SRS is configured to generate a recognition result specifying possible speech included in the audio signal and a confidence value indicating a confidence in a correctness of the speech result. The method also includes completing a portion of the speech recognition tasks including generating one or more recognition results and one or more confidence values for the one or more recognition results, determining whether the one or more confidence values meets a confidence threshold, aborting a remaining portion of the speech recognition tasks for SRS's that have not generated a recognition result, and outputting a final recognition result based on at least one of the generated one or more speech results.	02-27-2014
20140079204	Computing Device With Remote Contact Lists - In one implementation a computer-implemented method includes generating a group of telephone contacts for a first user, wherein the generating includes identifying a second user as a contact of the first user based upon a determination that the second user has at least a threshold email-based association with the first user; and adding the identified second user to the group of telephone contacts for the first user. The method further includes receiving a first request to connect a first telephone device associated with the first user to a second telephone device associated with the second user. The method also includes identifying a contact identifier of the second telephone device using the generated group of telephone contacts for the first user, and initiating a connection between the first telephone device and the second telephone device using the identified contact identifier.	03-20-2014
20140149119	SPEECH TRANSCRIPTION INCLUDING WRITTEN TEXT - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for transcribing utterances into written text are disclosed. The methods, systems, and apparatus include actions of obtaining a lexicon model that maps phones to spoken text and obtaining a language model that assigns probabilities to written text. Further includes generating a transducer that maps the written text to the spoken text, the transducer mapping multiple items of the written text to an item of the spoken text. Additionally, the actions include constructing a decoding network for transcribing utterances into written text, by composing the lexicon model, the inverse of the transducer, and the language model.	05-29-2014
20150149167	DYNAMIC SELECTION AMONG ACOUSTIC TRANSFORMS - Aspects of this disclosure are directed to accurately transforming speech data into one or more word strings that represent the speech data. A speech recognition device may receive the speech data from a user device and an indication of the user device. The speech recognition device may execute a speech recognition algorithm using one or more user and acoustic condition specific transforms that are specific to the user device and an acoustic condition of the speech data. The execution of the speech recognition algorithm may transform the speech data into one or more word strings that represent the speech data. The speech recognition device may estimate which one of the one or more word strings more accurately represents the received speech data.	05-28-2015
20150161985	PRONUNCIATION VERIFICATION - Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for verifying pronunciations. In one aspect, a method includes obtaining a first transcription for an utterance. A second transcription for the utterance is obtained. The second transcription is different from the first transcription. One or more feature scores are determined based on the first transcription and the second transcription. The one or more feature scores are input to a trained classifier. An output of the classifier is received. The output indicates which of the first transcription and the second transcription is more likely to be a correct transcription of the utterance.	06-11-2015
20150340034	RECOGNIZING SPEECH USING NEURAL NETWORKS - Methods, systems, and apparatus, including computer programs encoded on computer storage media, for recognizing speech using neural networks. One of the methods includes receiving an audio input; processing the audio input using an acoustic model to generate a respective phoneme score for each of a plurality of phoneme labels; processing one or more of the phoneme scores using an inverse pronunciation model to generate a respective grapheme score for each of a plurality of grapheme labels; and processing one or more of the grapheme scores using a language model to generate a respective text label score for each of a plurality of text labels.	11-26-2015

Francoise Becquey-Weisenburger, Stow, OH US

Patent application number	Description	Published
20120109750	METHOD FOR REDUCING UNWANTED PAPER ADVERTISEMENTS IN COMMERCE - A method for reducing unwanted paper advertisement mailings includes offering an interface for presenting advertisements from businesses for products or services to consumers, presenting the advertisement to the consumers, and providing the consumers with information for opting out of paper advertisement mailings from the businesses.	05-03-2012

Francoise Belaubre, Cugnaux FR

Patent application number	Description	Published
20100048729	Composition based on xanthoxyline and its use in cosmetic - The present invention relates to the use of xanthoxyline, and of plant extracts containing it, in cosmetic compositions.	02-25-2010
20100119632	CLEOME SPINOSA EXTRACT USED IN PHARMACEUTICAL PREPARATIONS AND COSMETIC COMPOSITIONS - The invention relates to a	05-13-2010

Francoise Bendetti, Paris FR

Patent application number	Description	Published
20110245486	METHOD FOR THE PRODUCTION OF 1,4-BENZOTHIEPIN-1,1-DIOXIDE DERIVATIVES - The invention relates to a method for producing 1,4-benzothiepin-1,1-dioxide derivatives substituted with benzyl groups.	10-06-2011

Francoise Bernerd, Nice FR

Patent application number	Description	Published
20120259000	EPIDERMAL DIFFERENTIATION MICRORNA SIGNATURE AND USES THEREOF - The present invention concerns a method for determining the state of epidermal differentiation of a human keratinocyte in a sample of human epithelium, comprising determining the level of expression of at least one miRNA selected from hsa-miR-455-3p, hsa-miR-141, hsa-miR-148a, hsa-miR-182, hsa-miR-224, hsa-miR-26a, hsa-miR-26b, hsa-miR-361-5p, hsa-miR-425, hsa-miR-92b, hsa-let-7i, hsa-miR-22, hsa-miR-221, hsa-miR-222, hsa-miR-29a, hsa-miR-29b, hsa-miR-663, hsa-miR-30a and hsa-miR-30c within said keratinocyte and comparing the level of expression of the selected miRNA or miRNAs with the mean level of expression of the selected miRNA or miRNAs in non-differentiated keratinocytes, or in differentiated epidermal keratinocytes, preferably originating from the same strain or from the same population. The present invention also concerns various uses of the method for determining the state of epidermal differentiation as well as pharmaceutical or cosmetic compositions.	10-11-2012
20140044799	MOLECULAR SIGNATURE OF CUTANEOUS PIGMENTARY SPOTS, ASSOCIATED WITH THE ORGANIZATION OF THE EXTRACELLULAR MATRIX - The present invention concerns a molecular signature of cutaneous pigmentary spots, comprising the genes MXRA5, LYZ, CTSL2, PLAU, TIMP1, EFEMP1, ECM1, ASPN, HS3ST6, PAPLN, CHSY1 and FLRT2, and various applications of this signature. In particular, the invention concerns a method for characterizing a known or suspected pigmentary spot in a human being, comprising comparing the levels of expression in skin samples obtained from said spot and from adjacent undamaged skin, of at least one dermal gene linked to matrix remodelling or to its extracellular proteoglycan and glycoprotein components, selected from the list constituted by the genes MXRA5, LYZ, CTSL2, PLAU, TIMP1, EFEMP1, ECM1, ASPN, HS3ST6, PAPLN, CHSY1 and FLRT2. The invention also concerns methods for evaluating the efficacy of a pigmentary spot treatment, cosmetic and therapeutic methods for the treatment of pigmentary spots, and various modulators for said genes, and their use.	02-13-2014
20150307940	MOLECULAR SIGNATURE OF CUTANEOUS PIGMENTARY SPOTS, ASSOCIATED WITH THE EXTRACELLULAR MATRIX - The present invention concerns a molecular signature of cutaneous pigmentary spots, comprising the genes TGFBR2, TGFBI, BMP2, SMAD3, THBS2, TGFBR3, SEMA5A, SMAD7, SOSTDC1, FRAS1, LEPREL1, MATN2, DST, PLOD2, ITGA2, COL6A3, CRTAP, LAMC1, LAMB3, LAMA3, ITGAV, ITGB1 and ACTN1, and various applications of this signature. In particular, the invention concerns a method for characterizing a known or suspected pigmentary spot in a human being, comprising comparing the levels of expression in skin samples obtained from said spot and from adjacent undamaged skin, of at least one dermal gene linked to the extracellular matrix selected from the list constituted by the genes TGFBR2, TGFBI, BMP2, SMAD3, THBS2, TGFBR3, SEMA5A, SMAD7, SOSTDC1, FRAS1, LEPREL1, MATN2, DST, PLOD2, ITGA2, COL6A3, CRTAP, LAMC1, LAMB3, LAMA3, ITGAV, ITGB1 and ACTN1. The invention also concerns methods for evaluating the efficacy of a pigmentary spot treatment, cosmetic and therapeutic methods for the treatment of pigmentary spots, and various modulators for said genes, and their use.	10-29-2015

Francoise Bressolle, Montpellier FR

Patent application number	Description	Published
20100249142	IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS - Imidazo[1,2-a]quinoxaline compounds for the treatment of cancers as well as pharmaceutical compositions that include these compounds and their uses in therapy.	09-30-2010

Francoise Bridey, La Reine FR

Patent application number	Description	Published
20100193440	USE OF A CHROMATOGRAPHY SUBSTRATE FOR REDUCING THE AMOUNT OF ADAMTS13 IN A SOLUTION DERIVED FROM PLASMA - An ion-exchange chromatography support for reducing the ADAMTS13 amount present in a plasma-derived solution containing human von Willebrand factor. The support includes a large-pore, vinyl polymer-type resin bearing DEAE groups, and a buffer including trisodium citrate, sodium chloride, calcium chloride, glycine and lysine.	08-05-2010

Francoise Brun-Vezinet, Paris FR

Patent application number	Description	Published
20090253122	Method for measuring resistance of a patient HIV-2 to protease inhibitors - A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least one mutation at certain, specified, particular positions of the proteinic sequence of the protease of said viral strain from a biological sample taken from a patient contaminated by HIV 2 is searched. If said mutation is observed, the existence of a resistance to said anti-protease agent is assumed in the patient.	10-08-2009
20100209903	Method for measuring resistance of a patient HIV-2 to protease inhibitors - A search method in a biological sample containing an HIV-2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least one mutation at certain, specified, particular positions of the proteinic sequence of the protease of said viral strain from a biological sample taken from a patient contaminated by HIV-2 is searched. If said mutation is observed, the existence of a resistance to said anti-protease agent is assumed in the patient.	08-19-2010

Francoise Chabut, Meudon FR

Patent application number	Description	Published
20100295288	PRINTED IDENTIFICATION DOCUMENT AND PROCESS FOR PRINTING SUCH A DOCUMENT - The invention concerns the personalisation graphics of identification documents. The identification document comprises a body where at least one of the main surfaces forms a print surface, on which artwork (	11-25-2010
20150239202	SECURE DATA CARRIER AND METHOD OF PRODUCTION OF SAID SECURE DATA CARRIER - The present invention concerns a data carrier having—a central portion covered by at least one translucent protective layer on at least one of its sides,—at least one see-through portion with an orifice filled with a translucent plug, going at least partially through of the central portion. The central portion has a colored core and at least one opaque layer colored in a color different from the colored core in order to show a layered structure of different colors on the edge of the data carrier. The invention also concerns the method of production of such a data carrier.	08-27-2015

Francoise Chamouleau, L'Isle D'Espagnac FR

Patent application number	Description	Published
20090258405	Preparation of optically active alcohols with whole-cell catalysts - The present invention relates to a process for the preparation of optically active alcohols from ketones with the aid of whole-cell catalysts comprising an alcohol dehydrogenase and also an enzyme capable of cofactor regeneration, a substrate concentration of at least 500 mM of ketone being provided for the conversion and the conversion being carried out without the addition of an “external” cofactor.	10-15-2009

Francoise Chanteloube, Pau FR

Patent application number	Description	Published
20120009290	Compositions for skin diseases or disorders - Medicaments or cosmetic compositions for the treatment or alleviation of skin or mucous membrane diseases or disorders related to an enhanced level of anti-microbial peptides or proteins comprising	01-12-2012
20130071502	COMPOSITIONS FOR SKIN DISEASE OR DISORDERS - Medicaments or cosmetic compositions for the treatment or alleviation of skin or mucous membrane diseases or disorders related to an enhanced level of anti-microbial peptides or proteins comprising	03-21-2013

Francoise Chavrier, Lyon Cedex FR

Patent application number	Description	Published
20110009779	Method Of Treating An Ocular Pathology By Applying High Intensity Focused Ultrasound and Device Thereof - The present invention relates to a method of treating an ocular pathology by generating high intensity focused ultrasound onto at least one eye's area, said method comprises at least the following steps of: —positioning onto the eye a device capable of directing high intensity focused ultrasound onto at least one annular segment, —and generating high intensity focused ultrasound energy onto said segment to treat at least one annular segment in the eye.	01-13-2011
20120136281	PARAMETERS FOR AN ULTRASOUND DEVICE COMPRISING MEANS TO GENERATE HIGH INTENSITY ULTRASOUND BEAM - The present invention relates to a device for treatment of an ocular pathology, the device comprising at least one eye ring (	05-31-2012

Francoise Chavrier, Lyon Cedex 03 FR

Patent application number	Description	Published
20110301469	ULTRASOUND DEVICE COMPRISING MEANS TO GENERATE ULTRASOUND BEAM PRESENTING A CONCAVE SEGMENT SHAPE HAVING A SINGLE CURVATURE - A device for treatment of an ocular pathology characterized in that it comprises at least one eye ring (	12-08-2011

Francoise Colobert, Lampertheim FR

Patent application number	Description	Published
20100137659	PROCESS FOR THE SYNTHESIS OF 2,2',6-TRIBROMOBIPHENYL - A process for the synthesis of 2,2′,6-tribromobiphenyl.	06-03-2010
20140142325	P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS - Novel P-chirogenic organophosphorus compounds of general formula (I), a process for the synthesis of the compounds of formula (I), and intermediate products of general formulae (II), (III) and (IV), as shown below, are involved in the synthesis of compounds (I).	05-22-2014

Francoise Cormont, Rixensart BE

Patent application number	Description	Published
20080299134	Recombinant Anti-Interleukin-9 Antibodies - The application describes neutralizing chimeric and humanized anti-human IL-9 antibodies, and the use thereof to identify neutralizing epitopes on human IL-9 and as medicaments to prevent and treat asthma, bronchial hyperresponsiveness, atopic allergy, and other related disorders. Particularly disclosed are recombinant antibodies derived from three murine anti-human IL-9 antibodies identified infra as MH9A3, MH9D1, and MH9L1.	12-04-2008

Francoise Cottrez, Le Rouret FR

Patent application number	Description	Published
20090075372	OBTENTION OF FOOD- OR AUTO-ANTIGEN SPECIFIC TR1 CELLS FROM A LEUKOCYTE OR PBMC POPULATION - An in vitro method for the obtention of a food- or auto-antigen specific Tr1 cell population from a leukocyte or a PBMC population, includes stimulating the PBMC or leukocyte population with the food- or auto-antigen, and recovering the food- or auto-antigen specific Tr1 cell population from the stimulated cell population. Preferably, the PBMC or leukocyte population is re-stimulated at least once with the same antigen after step (1), in the presence of IL-2 and at least one interleukin selected from the group consisting of IL-4 and IL-13. The in vitro method may further include a third step of expanding the recovered antigen-specific Tr1 cell population, advantageously by contacting them with feeder cells capable of expressing factors necessary for the expansion. Preferably, the feeder cells are recombinant insect feeder cells.	03-19-2009
20090221070	In Vitro Production of a Cell Population Using Feeder Cells - A method for the in vitro production of a cell population P′ from a cell population P, the production requiring the presence of at least one factor which is expressed by feeder cells, wherein a) feeder cells proliferate at a temperature T	09-03-2009
20130005602	METHOD FOR EVALUATING THE SENSITIZING POTENTIAL OF A TEST COMPOUND - The invention relates to a method for evaluating the sensitizing potential of a test compound, and to a kit for implementing said method.	01-03-2013

Francoise Cottrez, Biot FR

Patent application number	Description	Published
20080233095	METHOD FOR OBTAINING ANTIGEN-SPECIFIC TR1 REGULATORY LYMPHOCYTES - The invention relates to a method for preparing antigen-specific Tr1 regulatory lymphocytes. The inventive method involves the use of artificial antigen-presenting cells, expressing a molecule from the HLA class II system and a human LFA-3 molecule and expressing none of the B7-1, B7-2, B7-H1, CD40, CD23 or ICAM-1 costimulation molecules.	09-25-2008

Francoise David-Tupinier, Toulouse FR

Patent application number	Description	Published
20080239973	METHOD OF DATA INTEGRITY CONTROL IN AN AFDX NETWORK - The invention relates to a data integrity checking system in a frame-switched on-board network, comprising at least first and second asynchronous transmitter terminals, with the second (	10-02-2008

Francoise Delongueville, Natoye BE

Patent application number	Description	Published
20100137144	METHOD AND MEANS FOR DETECTING AND/OR QUANTIFYING HIERARCHICAL MOLECULAR CHANGE OF A CELL IN RESPONSE TO AN EXTERNAL STIMULUS - The present invention is related to a method for detecting and/or quantifying hierarchical (regulated) molecular changes of a cell in response to any external stimulus.	06-03-2010

Francoise De Longueville, Natoye BE

Patent application number	Description	Published
20100113301	METHOD FOR THE IDENTIFICATION AND/OR THE QUANTIFICATION OF A TARGET COMPOUND OBTAINED FROM A BIOLOGICAL SAMPLE UPON CHIPS - The present invention is related to a method for the identification and/or the quantification of a target compound obtained from a sample, preferably a biological sample, comprising the steps of putting into contact the target compound with a capture molecule in order in order to allow a specific binding between said target compound with a capture molecule, said capture molecule being fixed upon a surface of a solid support according to an array comprising a density of at least 20 discrete regions per cm	05-06-2010

Francoise Del Turco, Lasne BE

Patent application number	Description	Published
20130089639	Low Glycaemic Index Baked Product Comprising High Levels of Fibre, Proteins and Inclusions - The present invention is directed to a bread product which is particularly adapted for breakfast, and which is characterized by high satietogenic and nutritional properties, and its convenience of use. Said bread product comprises 8-25 wt % of proteins, more than 6 wt % of fibres and 18-35 wt % of inclusions having an average size of at least 2 mm.	04-11-2013

Francoise Denamur, Rixensart BE

Patent application number	Description	Published
20090130145	VACCINE - The invention provides an attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7. The invention particularly provides a rotavirus population designated as P43. The invention further provides a novel formulation for a rotavirus vaccine which is in the form of a quick dissolving tablet for immediate dissolution when placed on the tongue.	05-21-2009

Francoise Denoyelle-Gryson, Sceaux FR

Patent application number	Description	Published
20090104600	Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.	04-23-2009
20120322059	MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.	12-20-2012
20140113285	MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.	04-24-2014

Francoise Dignat-George, Marseille FR

Patent application number	Description	Published
20100260724	METHOD FOR MEASURING THE PLASMINE ACTIVITY OF MICROPARTICLES PRESENT IN A SAMPLE OF A BIOLOGICAL FLUID AND USE THEREOF - The invention relates to a method for measuring the plasmine activity of microparticles, in particular circulating microparticles, in a sample of a biological fluid, particularly a biological fluid in a flow situation, wherein said method can be used as a diagnosis method or a method for following a treatment.	10-14-2010

Francoise Fabret, Versailles FR

Patent application number	Description	Published
20110131199	QUERY PLAN REFORMULATION - Apparatus, systems, and methods may operate to receive an original query plan, to transform the original query plan into an equivalent executable compact query plan, and to store the compact query plan on a machine readable device. Further activities may include computing maximal source sub-queries associated with the compact query plan, and computing semi-join reductions of the maximal source sub-queries to provide an executable derivative query plan, which may also be stored on a machine readable device. Additional apparatus, systems, and methods are disclosed.	06-02-2011
20110145301	Apparatus And Method For Producing A Virtual Database From Data Sources Exhibiting Heterogeneous Schemas - A computer readable medium includes executable instructions to define an individual publication schema for each heterogeneous source of a set of heterogeneous sources. Each individual publication schema specifies mapping rules between data from a heterogeneous source and a non-permanent structured instance of data. A non-permanent structured instance of data as defined by an individual publication schema is generated. An integration schema defining a set of integration rules for combining data from each non-permanent structured instance of data as defined by individual publication schema is established. A target non-permanent structured instance of data to include data from the plurality of heterogeneous sources based on at least one integration schema is formed.	06-16-2011
20130073537	QUERY PLAN REFORMULATION - Apparatus, systems, and methods may operate to receive an original query plan, to transform the original query plan into an equivalent executable compact query plan, and to store the compact query plan on a machine readable device. Further activities may include computing maximal source sub-queries associated with the compact query plan, and computing semi-join reductions of the maximal source sub-queries to provide an executable derivative query plan, which may also be stored on a machine readable device. Additional apparatus, systems, and methods are disclosed.	03-21-2013
20140089254	SYSTEMS AND METHODS FOR ROBUST DATA SOURCE ACCESS - A method for determining access to a data table store includes determining static properties of data sources during query design, loading the static properties into an unavailability table, at query execution evaluating dynamic properties of the data sources and updating the unavailability table, evaluating a preference expression by a table dispatcher component using session context information from the availability table, determining if a preferred table is available at query execution, and if available indicating to access the preferred table, else applying unavailability rules to obtain repair actions. The preference expression including a user-defined preference between an original table and its replica and user-defined repair actions, where a selection is made at query execution between an original data table and a replicated data table based on the unavailability rules. A non-transitory computer readable medium and a system for implementing the method are also disclosed.	03-27-2014

Francoise Falson, La Tour De Salvagny FR

Patent application number	Description	Published
20110111019	Novel Method for Producing Nanocapsules in the Absence of an Organic Solvent, and Nanocapsules Produced Thereby - The invention relates to a method for preparing an aqueous suspension of nanocapsules comprising an oily core surrounded by a polymeric shell, in which method the following phases are mixed:	05-12-2011
20130207286	NOVEL METHOD FOR PRODUCING NANOCAPSULES IN THE ABSENCE OF AN ORGANIC SOLVENT, AND NANOCAPSULES PRODUCED THEREBY - A method for preparing an aqueous suspension of nanocapsules comprising an oily core surrounded by a polymeric shell, comprises mixing first and second phases, wherein the first oily phase comprises a hydrophobic polymer, an oil or a mixture of oils, at least one active ingredient, and a surfactant TA	08-15-2013

Francoise Fayolle-Guichard, Clamart FR

Patent application number	Description	Published
20080210631	Polypeptides Having an Activity in the Mtbe Degradation Path and Uses Thereof - The invention concerns an isolated or purified polypeptide having an activity in the MTBE degradation path, and/or at least one of the catabolic intermediates of MTBE, preferably selected from the group consisting of tert-butyl alcohol (TBA), 2-methyl 1,2-propanediol (2-M1, 2-PD), hydroxyisobutyraldehyde, hydroxyiso-butyric acid (HIBA), said polypeptide being selected from the group consisting of: a) a polypeptide comprising a sequence of amino acids selected from the group consisting of SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8 or SEQ ID NO:10; b) a polypeptide comprising a sequence of amino acids having at least 70% identity, preferably 75%, 80%, 90%, 95%, 98% or 99% with the sequence of amino acids of a polypeptide as defined in a); a polypeptide as defined in a) or b) whereof the sequence of amino acids comprises a substitution, deletion, insertion, addition or mutation of one or several amino acids over its entire length.	09-04-2008

Francoise Fayolle-Guichard, Paris FR

Patent application number	Description	Published
20120178146	BACTERIA CAPABLE OF DEGRADING MULTIPLE PETROLEUM COMPOUNDS IN SOLUTION IN AQUEOUS EFFLUENTS AND PROCESS FOR TREATING SAID EFFLUENTS - This invention relates to new	07-12-2012
20140027375	BACTERIA OF THE GENUS PSEUDOXANTHOMONAS THAT ARE CAPABLE OF DEGRADING METHYL TERT-BUTYL ETHER (MTBE) INTO A SOLUTION IN EFFLUENT - This invention relates to bacteria of the genus	01-30-2014
20140030793	BACTERIA OF THE GENUS PSEUDONOCARDIA THAT ARE CAPABLE OF DEGRADING METHYL TERT-BUTYL ETHER (MTBE) OR ETHYL TERT-BUTYL ETHER (ETBE) INTO A SOLUTION IN EFFLUENT - This invention relates to bacteria of the genus	01-30-2014

Francoise Fenouillot, L'Isle D'Abeau FR

Patent application number	Description	Published
20080262159	Method of fabricating a power and/or telecommunications cable - A method of fabricating a power and/or telecommunications cable includes obtaining at least one layer of a material by thermally activating an elastomer composition containing a copolymer of ethylene vinyl acetate, a cyclic polyester oligomer, and a transesterification catalyst, where the material including nodules of polyester.	10-23-2008
20110301274	POWER AND/OR TELECOMMUNICATIONS CABLE HAVING IMPROVED FIRE-RETARDANT PROPERTIES - A method of preparation for a layer of material for use with a power and/or telecommunications cable includes mixing a composition including a thermoplastic polymer matrix and a phenolic resin. The phenolic resin is selected from the group consisting of novolac phenol-formaldehyde resins and novolac cyanate ester resins. The phenolic resin is hardened within the thermoplastic polymer matrix to obtain nodules of hardened phenolic resin dispersed throughout the material.	12-08-2011

Francoise Fenouillot, L'Isle D' Abeau FR

Patent application number	Description	Published
20080207813	Power and/or telecommunications cable having improved fire-retardant properties - The present invention provides a power and/or telecommunications cable including at least one layer of a material obtained from a composition comprising: a thermoplastic polymer matrix; and a phenolic resin; wherein said phenolic resin is selected from novolac phenol-formaldehyde resins and novolac cyanate ester resins, and wherein said material includes nodules of hardened phenolic resin dispersed throughout the material.	08-28-2008

Francoise Fenouillot-Rimlinger, L'Isle D'Abeau FR

Patent application number	Description	Published
20100048797	THERMOPLASTIC COMPOSITIONS HAVING IMPROVED PROPERTIES DURING AND AFTER PROCESSING STEPS, PROCESS FOR MANUFACTURING AN ARTICLE AND ARTICLE THUS OBTAINED - The present invention relates to a thermoplastic composition, said composition comprising at least one non-PVC thermoplastic matrix and at least one copolymer chosen from the group consisting of acrylic-based copolymer having an average molecular weight M	02-25-2010
20140288239	PBS- AND SILICA-BASED COMPOSITES - The present invention relates to PBS- and silica-based composites, said composites having a high swelling ability. It also relates to a method of preparing said composites, a method of swelling said composites and films obtained by swelling said composites.	09-25-2014
20150057424	POLYMERS, THE PROCESS FOR THE SYNTHESIS THEREOF AND COMPOSITIONS COMPRISING SAME - The present invention relates to copolymers, in particular poly(butylenesuccinate-co-furanoate) (PBSF) copolymers, which have advantageous mechanical properties, and also to polymeric compositions comprising them. It also relates to a process for preparing these polymers.	02-26-2015

Francoise Fenoullot, L'Isle D'Abeau FR

Patent application number	Description	Published
20130037305	ELECTRICAL CONDUCTOR COATED IN A BONDING LAYER, AND A METHOD OF MANUFACTURING SUCH AN ELECTRICAL CONDUCTOR - The invention relates to an electrical conductor coated in an insulating layer itself coated in a bonding layer, the conductor being characterized in that said bonding layer is obtained from a composition comprising a thermoplastics polymer and a settable resin. The invention also applies to a method of manufacturing such an electrical conductor coated in a bonding layer, the method being characterized in that it comprises applying said composition on said electrical conductor coated in said insulating layer, and applying treatment to cause said settable resin to be cured at least in part.	02-14-2013

Francoise Gevaudan, Beauchamp FR

Patent application number	Description	Published
20080274070	Method for permanently reshaping keratin fibers comprising applying a poorly concentrated reducing compositions followed by drying - The present disclosure relates to a method for permanently reshaping the keratin fibers, for example permanently reshaping the hair, comprising:	11-06-2008

Francoise Giulieri, Nice FR

Patent application number	Description	Published
20110011310	METHOD OF MANUFACTURING A COMPOSITE BASED ON COMPLEXES OF CONTROLLED STABILITY - The method for manufacturing a composite based on complexes of controlled stability over time using a fibrous inorganic matrix having tunnels and one or more organic compounds incorporated into said tunnels includes the following steps: the fibrous inorganic matrix having tunnels and the organic compound or compounds are provided; the fibrous inorganic matrix having tunnels is mixed with the organic compound or compounds so that said organic compound or compounds are incorporated into the tunnels of the fibrous inorganic matrix; the retention of the organic compound or compounds in said tunnels and their release therefrom by heating said mixture obtained, at a chosen temperature for a defined time, are controlled. The invention applies in particular in a preparation intended for cosmetic, pharmacological, nutri-therapeutic and agri-foodstuff, phytosanitary, petroleum or electronic usage or else in paints.	01-20-2011

Francoise Gueritte, Gif-Sur-Yvette FR

Patent application number	Description	Published
20130131084	USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER - The present invention relates to the use of derivatives of indoles having a general formula (I) as follow:	05-23-2013
20140235654	USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER - The present invention relates to the use of derivatives of indoles having a general formula (I) as follow:	08-21-2014

Francoise Guerlesquin, Marseille FR

Patent application number	Description	Published
20090163410	Novel Peptides and the Biological Use Thereof - The invention relates to novel purified insulated peptides, which exhibit, in particular, Nef protein-binding properties and are characterised in that they contain an amino acid sequence of a formula SEQ ID No 1: W-P-a-W-L-P, wherein a is selected from W, A, S or D.	06-25-2009

Francoise Henrio, Monteleger FR

Patent application number	Description	Published
20090246448	THERMOPLASTIC POLYMER/COLORANT TOW AND FLOCKED ARTICLES PREPARED THEREFROM - A continuous filament thermoplastic polymer/colorant tow, the filaments of which are formed from a composition containing at least one matrix including a thermoplastic polymer and a colorant, and, optionally, at least one light and/or heat stabilizer, and is converted into useful flocked articles, e.g., vehicle interiors, having such properties as good light and/or heat fastness.	10-01-2009

Francoise Hervagault US

Patent application number	Description	Published
20130274407	CATALYTIC SYSTEM FOR CONJUGATED DIENE POLYMERISATION, POLYMERISATION METHOD AND FUNCTIONAL POLYMER OBTAINED - The present invention relates to a novel catalytic system for polymerization, and more particularly for preparing conjugated diene polymers bearing a polar function at the chain end. This catalytic system is based on a metal salt of a rare-earth metal and, as alkylating agent, an organometallic compound based on a metal belonging to the 2	10-17-2013
20150108617	Method for Chemically Passivating a Surface of a Product Made of a III-V Semiconductor Material and the Product Obtained by Such a Method - A method for chemically passivating a surface of a product made of a III-V semiconductor material in which a) a P(N) polymer film is formed by deposition in a solvent comprising liquid ammonia. The film is formed by deposition, without electrochemical assistance, in the solvent, in the presence of an oxidizing chemical additive comprising phosphorous and generating electrical charge carriers in said surface.	04-23-2015

Francoise Houmeau, Paris FR

Patent application number	Description	Published
20090174780	Method and System for Synchronizing Colorimetric Rendering of a Juxtaposition of Display Surfaces - A method for making uniform the colorimetric rendering of a display surface including several adjacent display screens (	07-09-2009

Francoise Igersheim, Lyon FR

Patent application number	Description	Published
20120310012	METHOD FOR PREPARING A DEPEROXIDATION CATALYST - A process for preparing a deperoxidation catalyst comprising chromium as the main catalytic element is described. Also described, is a process for preparing an organic solution of a chromic acid ester. The solution can be used as a catalyst in a deperoxidation of an alkyl peroxide in a process for manufacturing cyclohexanol/cyclohexanone by oxidation of cyclohexane.	12-06-2012
20130046115	PROCESS FOR THE PRODUCTION OF AN ALKYL HYDROPEROXIDE - A method for preparing an alkyl hydroperoxide obtained by the oxidation of a saturated hydrocarbon using oxygen, preferably of a saturated cyclic hydrocarbon, is described. Also described, is a method for preparing cyclohexyl hydroperoxide by oxidizing cyclohexane with molecular oxygen or a gas containing molecular oxygen preferably in the absence of a catalyst.	02-21-2013
20130204038	PROCESS FOR THE OXIDATION OF HYDROCARBONS - A method for oxidizing hydrocarbons, in particular saturated hydrocarbons, for producing peroxides, alcohols, ketones, aldehydes and/or diacids is described. Also described, is a method for oxidizing a cycloaliphatic saturated hydrocarbon using molecular oxygen for producing ketones/alcohols, and more precisely for oxidizing cyclohexane into cyclohexanol and cyclohexanone using molecular oxygen.	08-08-2013

Francoise Jung, Zurich CH

Patent application number	Description	Published
20090118134	Template Fixed Beta-Hairpin Loop Mimetics and Their Use in Phage Display - Template-fixed β-hairpin mime tics of the general formula R	05-07-2009
20140213531	TEMPLATE-FIXED BETA-HAIRPIN PEPTIDOMIMETICS WITH PROTEASE INHIBITORY ACTIVITIY - Template-fixed β-hairpin peptidomimetics of the general formulae	07-31-2014

Francoise Le Bolzer, Rennes FR

Patent application number	Description	Published
20090073047	Antenna System With Second-Order Diversity and Card for Wireless Communication Apparatus Which is Equipped With One Such Device - The present invention relates to an antenna system with a diversity order of 2 comprising on a same substrate comprising a metallization plane first and second radiating elements each constituted by an F-inverted type antenna printed on the metallization plane side, the first and second radiating elements being positioned perpendicularly to each other near the periphery of the substrate and being connected by their extremity forming a ground.	03-19-2009
20090085821	Versatile antenna system - The present invention relates to an antenna system designed to be used in a wireless link, having polarization directions, respectively for reception and emission identical to the polarization directions, respectively for emission and reception, presented by a similar system placed in a geometric configuration of use that is different from that of the said first system. The invention enables identical devices to be implemented in separate items of equipment and in distinct positions while enabling the antenna pair to function correctly.	04-02-2009
20090096695	Active Photonic Forbidden Band Antennae - The present invention relates to an active photonic band gap antenna. In this case, the photonic band gap structure is constituted by metal rods, some of which are discontinuous, namely composed of sections of rods connected by a switching element such as a PIN diode. According to the invention, only one rod in a row of rods seen from the radiating source is discontinuous. The antenna pattern can be controlled at a low cost.	04-16-2009
20090153425	Dual-Band Antenna Front-End System - The present invention relates to a multiple-port dual-band antenna system and the associated interface formed by DPDT or SPDT switches, that can be integrated on one and the same multi-layer structure.	06-18-2009
20100039190	SLOT-LINE TYPE MICROWAVE DEVICE WITH A PHOTONIC BAND GAP STRUCTURE - The present invention relates to a microwave device of the slot-line type with a photonic band gap structure, comprising at least:	02-18-2010
20150095502	METHOD FOR CONNECTING A FIRST HOST AND A SECOND HOST WITHIN AT LEAST ONE COMMUNICATION NETWORK THROUGH A RELAY MODULE, CORRESPONDING RELAY MODULE - The invention concerns a relay module comprising a capturing module for intercepting a first connection establishment request sent by a first host; a communication module configured for sending a second connection establishment request to establish an initial auxiliary connection between the relay module and a second host and for receiving, from said second host, a first acknowledgment response and a context discovery unit configured for activating:	04-02-2015

Francoise Lohezic-Le-Devehat, Orgeres FR

Patent application number	Description	Published
20120329868	PARACONIC ACIDS AS PIGMENTATION ACTIVATORS - The invention relates to a mixture comprising protolichesterinic acid or a salt thereof or a diastereoisomer thereof or a derivative thereof, and lichesterinic acid or a salt thereof or an enantiomer thereof or a derivative thereof, for use for stimulating pigmentation of the skin and/or of its appendages.	12-27-2012
20150105459	LICHESTERINIC ACID AND THE DERIVATIVES OF SAME AS PIGMENTATION INHIBITORS - The invention relates to the cosmetic use of a compound chosen from the compounds of formula (A) and the salts of same as an agent for depigmenting the skin and/or keratinous appendages.	04-16-2015

Francoise Marga, Columbia, MO US

Patent application number	Description	Published
20110313542	ENGINEERED BIOLOGICAL NERVE GRAFT, FABRICATION AND APPLICATION THEREOF - An engineered three-dimensional structure includes living cells cohered with each other. The living cells suitably include Schwann cells and at least one other type of cell. The cells accompanying the Schwann cells can suitably be bone marrow stem cells or another type of cell having one or more anti-inflammatory properties. The structure is suitably a graft that facilitates restorative axon growth when the graft is implanted between the proximal and distal stubs of a severed nerve in a living organism. The graft can optionally include a plurality of acellular conduits extending between opposite axial ends of the graft. Bio-printing techniques can be used to assemble a three-dimensional construct that becomes through maturation an axon-guiding graft, by stacking a plurality of multicellular bodies, each of which includes a plurality of living cells cohered to one another to sufficiently to avoid collapsing when the multicellular bodies are stacked to form the structure.	12-22-2011
20130029008	ENGINEERED COMESTIBLE MEAT - Provided are engineered meat products formed as a plurality of at least partially fused layers, wherein each layer comprises at least partially fused multicellular bodies comprising non-human myocytes and wherein the engineered meat is comestible. Also provided are multicellular bodies comprising a plurality of non-human myocytes that are adhered and/or cohered to one another; wherein the multicellular bodies are arranged adjacently on a nutrient-permeable support substrate and maintained in culture to allow the multicellular bodies to at least partially fuse to form a substantially planar layer for use in formation of engineered meat. Further described herein are methods of forming engineered meat utilizing said layers.	01-31-2013
20140093618	ENGINEERED COMESTIBLE MEAT - Provided are engineered meat products formed as a plurality of at least partially fused layers, wherein each layer comprises at least partially fused multicellular bodies comprising non-human myocytes and wherein the engineered meat is comestible. Also provided are multicellular bodies comprising a plurality of non-human myocytes that are adhered and/or cohered to one another; wherein the multicellular bodies are arranged adjacently on a nutrient-permeable support substrate and maintained in culture to allow the multicellular bodies to at least partially fuse to form a substantially planar layer for use in formation of engineered meat. Further described herein are methods of forming engineered meat utilizing said layers.	04-03-2014

Francoise Massines, Sorede FR

Patent application number	Description	Published
20140042130	Plasma Treatment of Substrates - A process for plasma treating a substrate comprises applying a radio frequency high voltage to at least one electrode positioned within a dielectric housing having an inlet and an outlet while causing a process gas, usually comprising helium, to flow from the inlet past the electrode to the outlet, thereby generating a non-equilibrium atmospheric pressure plasma. An atomised or gaseous surface treatment agent is incorporated in the non-equilibrium atmospheric pressure plasma. The substrate is positioned adjacent to the plasma outlet so that the surface is in contact with the plasma and is moved relative to the plasma outlet. The velocity of the process gas flowing past the electrode is less than 100 m/s. Process gas is also injected into the dielectric housing at a velocity greater than 100 m/s. The volume ratio of process gas injected at a velocity greater than 100 m/s to process gas flowing past the electrode at less than 100 m/s is from 1:20 to 5:1.	02-13-2014
20140248444	Plasma Treatment Of Substrates - An apparatus for plasma treating a substrate comprises a high voltage source of frequency 3 kHz to 30 kHz connected to at least one needle electrode (	09-04-2014

Francoise Mathieu-Daude, Saint Clement De Riviere FR

Patent application number	Description	Published
20110165597	METHOD FOR THE SCREENING OF CONSERVED SECRETED PROTEINS - Conserved polypeptides from protozoan parasitic species which are secreted through the endoplasmic reticulum/Golgi dependent secretory pathway, their identification and their use.	07-07-2011

Francoise Megret, Paris FR

Patent application number	Description	Published
20090068213	Early detection of flaviviruses using the NS1 glycoprotein - The invention concerns a method for early detection of a flavivirus-induced infection, comprising the detection of the flavivirus non-structural glycoprotein NS1 in a biological sample during the clinical phase of the infection, by an immunological method using at least two identical or different antibodies, the first antibody consisting of polyclonal or monoclonal antibodies pre-selected for their high affinity for said NS1 protein hexameric in shape.	03-12-2009

Francoise Mennechez, Checy FR

Patent application number	Description	Published
20110168005	GLAZING WITH INCREASED BULLET RESISTANCE - The subject of the invention is:	07-14-2011

Francoise Mennechez, Orleans FR

Patent application number	Description	Published
20080264930	Electric Heating Structure - An electric heating structure including a substrate and a heating element having a given specific resistance. The heating element includes an electrically conductive layer deposited on one of the faces of the substrate and supplied electrically, the heating element including a network of patterns functionally connected to the electrically conductive layer.	10-30-2008
20090246476	DECORATED LAYER STRUCTURE AND THE PRODUCTION THEREOF - The invention relates to a decorated structure (	10-01-2009

Francoise Muscatelli, Cedex 09 Marseille FR

Patent application number	Description	Published
20130102528	Methods and Pharmaceutical Composition for the Treatment of a Feeding Disorder with Early-Onset in a Patient - The present invention relates to a compound which is an agonist of the oxytocin receptor o for use in the treatment of a feeding disorder with early-onset. In a particular embodiment, the agonist of the oxytocin receptor is the oxytocin or an active fragment thereof.	04-25-2013

Francoise Nielloud, Castelnau Le Lez FR

Patent application number	Description	Published
20100068307	DERMATOLOGICAL EMULSION AND METHOD FOR THE PREPARATION THEREOF - A foaming gelled composition in the form of a stable oil-in-water microemulsion comprising a fatty phase of microdroplets dispersed in an aqueous phase and a dermatological active ingredient, characterized in that it comprises a surfactant system comprising:—at least one ethoxylated nonionic surfactant;—at least one cosurfactant for stabilizing the ethoxylated nonionic surfactant;—at least one nonethoxylated hydrophilic nonionic surfactant;—at least one foaming agent chosen from the group of anionic surfactants.	03-18-2010

Francoise Ouarne, Castanet Tolosan FR

Patent application number	Description	Published
20100006091	METHOD AND EQUIPMENT FOR PRODUCING FRUIT SUGAR SYRUPS HAVING HIGH FRUCTOSE CONTENT - A method for preparing a sugar syrup having high fructose content, is implemented using at least one fruit containing sorbitol, particularly apples, pears, plums, prunes, peaches, nectarines, apricots and grapes, from which a first juice is extracted. The first juice is processed in order to obtain a clarified and demineralised sweet juice having a colour lower than 45 ICUMSA and having a conductometric ash content lower than 0.4%. The clarified and demineralised sweet juice is then processed in order to hydrolyse the saccharose into fructose and glucose. The method further includes an isomerisation of the glucose in fructose, and removing the sorbitol naturally occurring in the starting material.	01-14-2010

Francoise Pataut, Kanagawa JP

Patent application number	Description	Published
20130205515	READY-TO-USE COSMETIC COMPOSITION FOR OXIDATION DYEING KERATIN FIBERS - The present invention relates to a cosmetic composition for oxidation dyeing keratin fibers comprising, in an aqueous medium: (1) at least one oxidation dye; (2) at least one oxidizing agent; and (3) 1.5 wt % or more, relative to the total weight of the composition, of at least one amphoteric surfactant which is preferably a betaine-type amphoteric surfactant that may preferably be selected from the group consisting of alkylbetaines, sulfobetaines, alkylamidoalkylbetaines and alkylamidoalkylsulfobetaines, in particular alkylbetaines. The present invention is useful because the cosmetic composition according to the present invention can be prepared by a simple and inexpensive process, avoiding potential compatibility issues, and can provide better cosmetic properties and color intensity.	08-15-2013

Francoise Pecker, Creteil FR

Patent application number	Description	Published
20110144205	Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure - The present invention relates to a method for screening an asymptomatic patient at risk for heart failure, said method comprising measuring the concentration of glutathione in a blood sample obtained from said patient.	06-16-2011

Francoise Pflumio, Vitry/siene FR

Patent application number	Description	Published
20120122204	LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA - The present invention provides nucleic acid, vectors, viruses, and recombinant cells comprising triple-stranded structures, such as those resulting from central initiation and termination of HIV-1 reverse transcription at the center of HIV-1 linear DNA genomes. These triplex structures can act as a cis-determinant of HIV-1 DNA nuclear import, allowing infection of non-dividing target cells. In one aspect, the presence of the DNA triplex sequence in an HIV vector strongly stimulates gene transfer in hematopoietic stem cells. The invention also provides methods of using these triplex structures for making recombinant cells, as well as methods of using the recombinant cells to express proteins of interest both in vitro and in vivo.	05-17-2012
20120122963	LENTIVIRAL TRIPLEX DNA, AND VECTORS AND RECOMBINANT CELLS CONTAINING LENTIVIRAL TRIPLEX DNA - The present invention provides nucleic acid, vectors, viruses, and recombinant cells comprising triple-stranded structures, such as those resulting from central initiation and termination of HIV-1 reverse transcription at the center of HIV-1 linear DNA genomes. These triplex structures can act as a cis-determinant of HIV-1 DNA nuclear import, allowing infection of non-dividing target cells. In one aspect, the presence of the DNA triplex sequence in an HIV vector strongly stimulates gene transfer in hematopoietic stem cells. The invention also provides methods of using these triplex structures for making recombinant cells, as well as methods of using the recombinant cells to express proteins of interest both in vitro and in vivo.	05-17-2012

Francoise Pierard, Oxfordshire GB

Patent application number	Description	Published
20080287444	PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III:	11-20-2008
20110263575	Compounds Useful as Protein Kinase Inhibitors - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.	10-27-2011

Francoise Pierard, Abingdon GB

Patent application number	Description	Published
20090176763	Azaindoles useful as inhibitors of JAK and other protein kinases - The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.	07-09-2009
20100280026	COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides processes for preparing the compounds, pharmaceutically acceptable compositions comprising the compounds, and methods of using the compounds and compositions in the treatment of various disease, conditions, or disorders.	11-04-2010
20110086856	COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.	04-14-2011
20120183577	COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides processes for preparing the compounds, pharmaceutically acceptable compositions comprising the compounds, and methods of using the compounds and compositions in the treatment of various disease, conditions, or disorders.	07-19-2012
20120258958	AZAINDOLES USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES - The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.	10-11-2012
20130096128	PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III:	04-18-2013
20130345197	AZAINDOLES USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES - The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.	12-26-2013
20140018352	COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.	01-16-2014
20140163000	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	06-12-2014
20140187772	PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS - This invention describes novel pyrazole compounds of formula III:	07-03-2014
20140249138	AZAINDOLES USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES - The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.	09-04-2014
20140249157	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	09-04-2014
20140275009	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	09-18-2014
20140275021	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	09-18-2014
20140275130	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	09-18-2014
20150152103	AZAINDOLES USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES - The present invention relates to inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.	06-04-2015
20150158872	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and solid forms of the compounds of this invention.	06-11-2015
20150291601	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	10-15-2015
20150299205	COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE - The present invention relates to compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors.	10-22-2015

Francoise Portaels, Brussels BE

Patent application number	Description	Published
20090068651	Method for the detection of the antibiotic resistance spectrum of mycobacterium species - Method for the detection of the antibiotic resistance spectrum of	03-12-2009

Francoise Porteu, Paris FR

Patent application number	Description	Published
20140051631	PHARMACEUTICAL COMPOSITION COMPRISING TPO OR AN AGONIST OF THE TPO RECEPTOR - The present invention relates to a new use of TPO or a TPO/mpl receptor agonist as an adjuvant of a treatment of a neoplastic disease by irradiation or chemotherapeutic agents in order to prevent genomic instability of hematopoietic stem cells incurred through radio- or chemotherapy and hence to prevent the occurrence of secondary cancers, namely acute myelogenous leukemia and myelodisplasia.	02-20-2014

Francoise Poulat, Sciez FR

Patent application number	Description	Published
20120308689	METHOD FOR PRODUCING PLASTIC CONTAINERS BY STRETCH BLOW MOLDING, PREFORM, CONTAINER AND USE OF SUCH A CONTAINER - Hollow plastic containers provided with a narrow opening and a body having a base and at least one side wall extending longitudinally between the narrow opening and the base, such as bottles or similar, are obtained from preforms by stretch blow molding. A blend of polyethylene terephtalate (PET) and polytrimethylene terephtalate (PTT), with a weight proportion of PTT in the range 5-50% is injected to obtain the preform. During the stretch blow molding step, the multi polyester preform undergoes longitudinal stretching at a longitudinal ratio of between approximately 3.5 and 6 and radial stretching at a ratio of between approximately 4 and 9. The body of the preform is subjected to an overall stretching ratio included between 16 and 50, whereby the weight of the container produced by stretch-blow molding may be reduced.	12-06-2012
20140197580	METHOD FOR PRODUCING A BIO-PET POLYMER - The invention relates to a method for producing a bio-PET polymer comprising the following steps: Step A) providing at least one diacid compound, comprising a terephtalate compound; Step B) providing at least one diol compound, comprising monoethylene glycol; wherein—at least one of the terephtalate compound and/or the monoethylene glycol is obtained from at least one bio-based material, and—at least one of the diacid compound and/or the diol compound further comprises at least one crystallization retarding compound; and Step C) copolymerizing a mixture of the diacid compound and the diol compound to obtain a bio-PET polymer comprising diacid units and diol units, comprising up to 7.5 mol % of unit(s) corresponding to the at least one crystallization retarding compound, based on the total number of moles of diacid units contained in the bio-PET. The invention also relates to a method for producing a bio-PET packaging element, comprising the following steps:—performing the method described above; and—Step D) converting the bio-PET into the bio-PET packaging element.	07-17-2014

Francoise Redini, Sautron FR

Patent application number	Description	Published
20100311695	HYDROXY-BISPHOSPHONIC ACID DERIVATIVES AS VECTOR TARGETING BONE TISSUE - The present invention relates to hydroxy-bisphosphonic acid derivatives corresponding to general formula (I): in which: -n and m denote, independently of one another, an integer ranging from 1 to 4, —X denotes an oxygen atom or an N—R3 group, —R1 and R3 denote, independently of one another, a linear or branched C	12-09-2010

Francoise Rochange, Ramonville St Agne FR

Patent application number	Description	Published
20110230352	TREATMENT PROCESS FOR A SUPERIOR PLANT IN ORDER TO CONTROL ITS GROWTH AND ARCHITECTURE - A treatment process for a superior plant in order to control the growth of the plant, is characterized in that an adapted quantity of strigolactones is brought in contact with the plant so as to inhibit the formation of at least one ramification. A method of using strigolactones to identify genes and/or molecules involved in the growth of buds and/or ramifications in superior plants is also disclosed.	09-22-2011

Francoise Sailhan, Athlone IE

Patent application number	Description	Published
20100142409	Self-Forming Network Management Topologies - The present invention relates to a network management system, a network element and a method for managing the network management system, the system operating in a computer or telecommunication network. The network comprises at least one network element that is able to communicate in the network through links. A network management software is contained and run on the network element. According to the present invention the network management software comprises controlling means for each management function or functions that the network element is part of, the controlling means being able to form, reform and/or terminate the topology for the management function. It further comprises register means for each management function or functions that the network element is part of, the register means being able to register and share information about the topology for the management function.	06-10-2010
20100281150	Method of Processing Event Notifications and Event Subscriptions - A method of processing event notifications and event subscriptions in a telecommunications or data network comprising a plurality of nodes, wherein an individual node performs the steps of maintaining a first repository for storing a set of event subscriptions encoded in a first summary and maintaining a second repository for storing the set of event subscriptions. The node encodes a received event notification into a second summary and then checks if the received event notification is a member of the set by comparing the first summary and the second summary. If the event notification is not a member of the set said notification is discarded.	11-04-2010

Francoise Saucy, Blonay CH

Patent application number	Description	Published
20090123542	PRIMARY COMPOSITION COMPRISING A LIPOPHILIC BIOACTIVE COMPOUND - The invention relates to a primary composition in which at least one lipophilic bioactive compound is mixed with a whey protein, present in an amount effective to increase the bioavailability of the lipophilic bioactive compound. The invention also relates to an oral composition that contains the primary composition in a foodstuff, in a food supplement, or in a pharmaceutical preparation, and to a cosmetic preparation that contains the primary composition. Methods for increasing the bioavailability of the lipophilic bioactive compound and providing increased photostability and oxidation resistance are also provided.	05-14-2009

Francoise Serein-Spirau, Montpellier FR

Patent application number	Description	Published
20130260471	USE OF CYCLIC AZABORONATES AS SENSITIVE MATERIALS IN SENSORS FOR DETECTING THE PRESENCE OF PEROXIDES IN A GASEOUS ENVIRONMENT - The invention concerns the use of cyclic azaboronates as sensitive materials in sensors for the detection of the presence of peroxides, in particular hydrogen peroxide, in a gaseous environment.	10-03-2013

Francoise Steltzlen, Chatou FR

Patent application number	Description	Published
20080310578	Pressurizer Heater for the Primary Cooling System of a Pressurized-Water Nuclear Reactor - The invention relates to a heating rod for a pressurizer of a primary cooling system of a pressurized-water nuclear reactor, the rod comprising a metal outer shell (	12-18-2008

Francoise Van Buylaere, Brussels BE

Patent application number	Description	Published
20110031896	LIGHTING DEVICE FOR LIGHTING THE AIRFIELD OF AN AIRPORT - The invention relates to a lighting device (	02-10-2011

Francoise Vauzelle-Kervroedan, Les Molieres FR

Françoise Baleux, Paris FR

Patent application number	Description	Published
20080242601	Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization - The present invention relates to polypeptides that inhibit the NF-&kgr; B signaling pathway and polynucleotides encoding the same. The present invention further provides methods for the modulation of and/or treatment of inflammatory responses, oncogenesis, viral infection; the regulation of cell proliferation and apoptosis; and regulation of B or T lymphocytes in antigenic stimulation, by administering the polypeptides of the present invention to a subject in need thereof. Finally, the present invention provides a method of identifying polypeptides that modulate oligomerization of NEMO.	10-02-2008
20080293620	Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections - A method for diagnosing an infection in a patient likely to be infected with a pathogenic microorganism, comprising the detection of CD4+ T lymphocytes recognizing at least one glycopeptide derived from said pathogenic microorganism, essentially consisting of a glycosylated T epitope, comprising from 14 to 25 amino acids, among which at least one neutral amino acid is bonded to a disaccharide or to a trisaccharide, and at least 15% of said amino acids are prolines, one of the prolines being located in position −1 to −4, relative to the position of said neutral amino acid.	11-27-2008
20100240040	METHOD FOR SCREENING FOR SELECTIVE MODULATOR OF THE NF-KB PATHWAY ACTIVATION - The invention relates to methods for screening for selective modulator of NF-κB pathway activation. The invention concerns methods for primary screening molecules that potentially modulate (activate or inhibit) the NF-κB pathway activation by identifying and selecting molecules modulate the interaction of NEMO with other proteins. The invention also concerns methods for secondary screening for modulator (activator or inhibitor) of the NF-κB pathway activation.	09-23-2010
20110015368	CD4-RECEPTOR-DERIVED PEPTIDES AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to an activated peptide derived from the CD4 receptor, which is capable of coupling by covalent bonding to an organic molecule and thus makes it possible to generate multiple potentially antiviral derivatives. The present invention also relates to a conjugated molecule comprising the CD4-receptor-derived peptide and an organic molecule, preferably the GPR1 peptide or a polyanion. Such a conjugated molecule can in particular be used in antiviral treatments, in particular the treatment of AIDS. The invention also relates to the methods for preparing the activated peptide derived from the CD4 receptor and the conjugated molecule.	01-20-2011
20110034383	CXCL12 GAMMA A CHEMOKINE AND USES THEREOF - Fragments of CXCL12 Gamma A chemokine having improved chemotaxis activity in vivo defined by an unprecedented capacity to associate and immobilise on extracellular glycans.	02-10-2011
20110105412	CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS - This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS.	05-05-2011
20130243751	GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI - A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by	09-19-2013
20140107043	NEW CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANIONIC POLYPEPTIDE FOR THE TREATMENT OF AIDS - This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Said organic molecule comprises a 5 to 21 amino acid anionic polypeptide. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS.	04-17-2014
20140161793	GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI - A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by	06-12-2014
20140336119	POLYPEPTIDES TARGETING GLYCOSYLATED MUC2 PROTEINS, METHODS OF SYNTHESIS, THEIR NUCLEIC ACIDS AND USES THEREOF - The invention relates to polypeptides, defined through a consensus sequence, having a length from 10 to 80 amino-acid residues, and whose polypeptidic sequence comprises or consists of the consensus sequence P1(X	11-13-2014

Françoise Baleux, Paris FR

Patent application number	Description	Published
20110015368	CD4-RECEPTOR-DERIVED PEPTIDES AND METHOD FOR THE PREPARATION THEREOF - The present invention relates to an activated peptide derived from the CD4 receptor, which is capable of coupling by covalent bonding to an organic molecule and thus makes it possible to generate multiple potentially antiviral derivatives. The present invention also relates to a conjugated molecule comprising the CD4-receptor-derived peptide and an organic molecule, preferably the GPR1 peptide or a polyanion. Such a conjugated molecule can in particular be used in antiviral treatments, in particular the treatment of AIDS. The invention also relates to the methods for preparing the activated peptide derived from the CD4 receptor and the conjugated molecule.	01-20-2011
20110105412	CONJUGATED MOLECULES COMPRISING A PEPTIDE DERIVED FROM THE CD4 RECEPTOR COUPLED TO A POLYANION FOR THE TREATMENT OF AIDS - This invention relates to a conjugated molecule comprising a peptide derived from the CD4 receptor coupled to an organic molecule by means of a linker as well as a process for its preparation. Such a conjugated molecule can be used in antiviral treatment, namely in the treatment of AIDS.	05-05-2011
20130243751	GLYCOCONJUGATES AND THEIR USE AS POTENTIAL VACCINES AGAINST INFECTION BY SHIGELLA FLEXNERI - A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by	09-19-2013

Françoise Belaubre, Villeneuve Tolosane FR

Patent application number	Description	Published
20120093749	USE OF DELTA-TOCOPHERYL-CARBOHYDRATE AS A DEPIGMENTING AGENT - The present invention relates to a cosmetic or pharmaceutical composition for cutaneous application, whose goal is the depigmentation of the skin.	04-19-2012
20130177515	MONOTERPENE DERIVATIVES OF CHALCONE OR DIHYDROCHALCONE AND THEIR USE AS DEPIGMENTING AGENTS - The present invention relates to new monoterpene derivatives of chalcone or dihydrochalcone and their use as a depigmenting agent.	07-11-2013

Françoise Belaubre, Villeneuve Tolosane FR

Patent application number	Description	Published
20130108568	XANTHENEDIONE DERIVATIVES FOR THE TREATMENT OF PIGMENTATION AND SKIN AGEING DISORDERS	05-02-2013
20130177515	MONOTERPENE DERIVATIVES OF CHALCONE OR DIHYDROCHALCONE AND THEIR USE AS DEPIGMENTING AGENTS - The present invention relates to new monoterpene derivatives of chalcone or dihydrochalcone and their use as a depigmenting agent.	07-11-2013
20140050683	HETEROCYCLIC RESORCINOL DERIVATIVES, PREPARATION OF SAME AND COSMETIC USES THEREOF - The invention relates to a compound of general formula (I)	02-20-2014
20140348768	ACRIDINEDIONE DERIVATIVES FOR TREATING PIGMENTATION DISORDERS AND AGEING OF THE SKIN - The present invention relates to a compound of general formula (I) in which: —R	11-27-2014

Françoise Bernerd, Paris FR

Patent application number	Description	Published
20100055694	Molecular signature representative of dysfunctions in epidermal homeostasis - The present invention concerns a method for evaluating the epidermal homeostasis of the skin of a subject, comprising differential analysis of the expression of a gene, preferably of two genes, selected from the group of genes consisting of KRT6B, KRT16, ESRRA, CBX3, MAP3K5, TRIO, PIK3CD, TCRB, PRRG2, ICP22BP, GPX3, GBA, BPGM, NID1, SMT3H2, LGALS2, DOC1, PRKCG, S100A8, S100A9, S100A2, S100A7, K15, SPRR1B and GSN in response to a physical or chemical challenge of the stratum corneum. It also concerns various methods for diagnosing the state of the epidermis of an individual and methods for detecting and screening products or procedures which can improve epidermal homeostasis. The invention also pertains to kits and arrays which can be used in these various methods and processes.	03-04-2010

Françoise Bernerd, Paris FR

Patent application number	Description	Published
20090239254	Functional pigmented skin equivalent - An in vitro skin equivalent includes at least one epidermis equivalent and at least one dermis equivalent, and further includes melanocytes constitutively producing melanin and fibroblasts.	09-24-2009
20100055694	Molecular signature representative of dysfunctions in epidermal homeostasis - The present invention concerns a method for evaluating the epidermal homeostasis of the skin of a subject, comprising differential analysis of the expression of a gene, preferably of two genes, selected from the group of genes consisting of KRT6B, KRT16, ESRRA, CBX3, MAP3K5, TRIO, PIK3CD, TCRB, PRRG2, ICP22BP, GPX3, GBA, BPGM, NID1, SMT3H2, LGALS2, DOC1, PRKCG, S100A8, S100A9, S100A2, S100A7, K15, SPRR1B and GSN in response to a physical or chemical challenge of the stratum corneum. It also concerns various methods for diagnosing the state of the epidermis of an individual and methods for detecting and screening products or procedures which can improve epidermal homeostasis. The invention also pertains to kits and arrays which can be used in these various methods and processes.	03-04-2010

Françoise Brochard-Wyart, Saint-Cloud FR

Patent application number	Description	Published
20110206751	STIMULATABLE ASYMMETRICAL POLYMERSOME - The invention relates to a polymer vesicle with an asymmetrical unilamellar membrane, said membrane being constituted by two distinct layers, a layer (A) and a layer (B), said layers comprising respective amphiphilic block copolymers with layer (A) comprising, in contrast to said layer (B), an effective quantity of amphiphilic block copolymer comprising at least one stimulatable hydrophobic polymer block, said block polymers provided by said copolymers being capable of adopting a new steric configuration in response to an exogenous stimulus, conditioning the rupture of said unilamellar membrane. The invention also provides a method of producing said vesicle, a method of encapsulating an active ingredient in said vesicles, and a method of controlled release of the active ingredient.	08-25-2011

Françoise Budar, Les Molieres FR

Patent application number	Description	Published
20100299779	METHOD OF PRODUCING DOUBLE LOW RESTORER LINES OF BRASSICA NAPUS HAVING A GOOD AGRONOMIC VALUE - The invention relates to a method of producing a double low restorer line of	11-25-2010

Françoise Budar, Les Molieres FR

Patent application number	Description	Published
20100299779	METHOD OF PRODUCING DOUBLE LOW RESTORER LINES OF BRASSICA NAPUS HAVING A GOOD AGRONOMIC VALUE - The invention relates to a method of producing a double low restorer line of	11-25-2010

Françoise Cailler, Montpellier FR

Patent application number	Description	Published
20110177062	METHODS FOR TREATING BREAST CANCER - The present disclosure is directed to methods of treating and preventing breast cancer or recurrence of breast cancer with compositions comprising anti-progastrin antibodies.	07-21-2011

Françoise Chavrier, Chezeneuve FR

Patent application number	Description	Published
20140257262	INTERSTITIAL ULTRASONIC DISPOSABLE APPLICATOR AND METHOD FOR TISSUE THERMAL CONFORMAL VOLUME ABLATION AND MONITORING THE SAME - An interstitial ultrasound thermal ablation applicator for conformal treatment of inhomogeneous tumor lesions includes: a body having a longitudinal axis, the body defining a hollow central channel along the longitudinal axis; and a plurality of CMUT array transducers mounted on the body, arranged side by side to form a cylindrical shape, having azimuth plans parallel to a longitudinal axis of the body, each of the plurality of CMUT array transducers having elevation dimensions predetermined to steer emitted ultrasonic waves to obtain a conformal volume treatment of the tumor lesions. An electronic driving method for driving an applicator having multiple independent transducer elements arranged in rows and columns includes: controlling focal parameters of each row and column of transducer elements; and controlling a contribution of each row and column of transducer elements in a manner to provide a conformal ablated volume.	09-11-2014
20150112235	APPARATUS FOR GENERATING FOCUSED ULTRASOUND WAVES WITH REDUCED TREATMENT TIME - The object of the invention relates to an apparatus for the thermal treatment of biological tissues by means of the application of focused ultrasound waves, the apparatus including:	04-23-2015

Françoise Corvaisier, Antony FR

Patent application number	Description	Published
20110040802	SHARED BUSINESS INTELLIGENCE ELEMENTS - Some aspects relate to reception of a selection of a business intelligence report element in a first business intelligence report of a first file format, creation of a serialized description of the business intelligence report element in a second file format based on a business intelligence report element data model, reception of an instruction to add the business intelligence report element to a second business intelligence report of a third file format, and addition of the business intelligence report element to the second business intelligence report in the third file format based on the serialized description of the business intelligence report element.	02-17-2011

Françoise Corvaisier, Antony FR

Patent application number	Description	Published
20110040802	SHARED BUSINESS INTELLIGENCE ELEMENTS - Some aspects relate to reception of a selection of a business intelligence report element in a first business intelligence report of a first file format, creation of a serialized description of the business intelligence report element in a second file format based on a business intelligence report element data model, reception of an instruction to add the business intelligence report element to a second business intelligence report of a third file format, and addition of the business intelligence report element to the second business intelligence report in the third file format based on the serialized description of the business intelligence report element.	02-17-2011

Françoise Delamadeleine, Antibes FR

Patent application number	Description	Published
20130116259	COMBINATION THERAPY FOR TREATING OR PREVENTING AN INFLAMMATORY SKIN DISORDER - Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an α2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.	05-09-2013

Françoise Delamadeleine, Antibes FR

Patent application number	Description	Published
20130116259	COMBINATION THERAPY FOR TREATING OR PREVENTING AN INFLAMMATORY SKIN DISORDER - Methods and compositions for improved treatment and prevention of an inflammatory skin disorder or a sign and/or symptom associated with the skin disorder are described. The methods involve topical application to the skin a combination of a therapeutically effective amount of an α2 adrenergic receptor agonist, such as brimonidine, and a therapeutically effective amount of a non-steroidal anti-inflammatory agent, such as diclofenac.	05-09-2013

Françoise De Laveleye-Defais, Brussels BE

Patent application number	Description	Published
20100105681	2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS - The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.	04-29-2010

Françoise De Laveleye-Defais, Brussels BE

Patent application number	Description	Published
20100105681	2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS - The present invention concerns 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.	04-29-2010

Françoise Denoyelle-Gryson, Sceaux FR

Patent application number	Description	Published
20120322059	MUTATION WITHIN THE CONNEXIN 26 GENE RESPONSIBLE FOR PRELINGUAL NON-SYNDROMIC DEAFNESS AND METHOD OF DETECTION - A purified polynucleotide having a chain of nucleotides corresponding to a mutated sequence, which in a wild form encodes a polypeptide implicated in hereditary sensory defect, wherein said mutated purified polynucleotide presents a mutation responsible for prelingual non-syndromic deafness selected from the group consisting of a specific deletion of at least one nucleotide.	12-20-2012

Françoise Dignat-George, Marseille FR

Patent application number	Description	Published
20110286963	HUMAN SOLUBLE CD146, PREPARATION AND USES THEREOF - The present invention relates to compositions and methods for modulating angiogenesis in vivo, ex vivo or in vitro. More particularly, the invention relates to a soluble CD 146 protein usable in the context of human therapy, as well as to corresponding antibodies. Particular forms of CD 146, herein described, may be used to mobilize, in vivo or ex vivo, both mature and immature endothelial cells, as well as to increase their influence on angiogenesis. The invention also relates to compositions comprising such compounds, particularly pharmaceutical or diagnostic compositions, including kits and the like, as well as methods of therapy or diagnosis using said compounds, compositions and cells.	11-24-2011

Françoise Gaill, Paris FR

Patent application number	Description	Published
20130004564	ANTIMICROBIAL PEPTIDES - The present invention relates to novel peptides having antimicrobial activity, and compositions containing the same.	01-03-2013

Françoise Gavini, Mons En Baroeul FR

Patent application number	Description	Published
20080274085	Probiotic Bifidobacterial Species - A probiotic composition comprising a	11-06-2008
20100310513	BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus	12-09-2010

Françoise Gavini, Mons En Baroeul FR

Patent application number	Description	Published
20100310513	BIFIDOBACTERIAL SPECIES - New bacterium GC61 belonging to the genus	12-09-2010

Françoise Giannetti Born Rouzaud, Toulouse FR

Patent application number	Description	Published
20140041168	FUNERAL URN WITH INDEPENDENT AND SECURED ATTACHED COMPARTMENTS - A funerary urn includes a receptacle (	02-13-2014

Françoise Giannetti Born Rouzaud, Toulouse FR

Patent application number	Description	Published
20120102794	TIMELESS IDENTIFICATION PASSPORT - A funerary article for the identification and perpetuation of the memory of a deceased individual in a timeless manner, made of unalterable material, includes: a marked element (	05-03-2012

Françoise Hervagault, Orsay FR

Patent application number	Description	Published
20120135857	NOVEL ORGANOMETALLIC COMPOUNDS CONTAINING A METAL BELONGING TO THE SECOND COLUMN OF THE PERIODIC TABLE, AND METHOD FOR PREPARING SAME - The present invention relates to a novel organometallic compound based on a divalent metal belonging to the 2	05-31-2012

Françoise Igersheim, Lyon FR

Patent application number	Description	Published
20120310012	METHOD FOR PREPARING A DEPEROXIDATION CATALYST - A process for preparing a deperoxidation catalyst comprising chromium as the main catalytic element is described. Also described, is a process for preparing an organic solution of a chromic acid ester. The solution can be used as a catalyst in a deperoxidation of an alkyl peroxide in a process for manufacturing cyclohexanol/cyclohexanone by oxidation of cyclohexane.	12-06-2012
20130046115	PROCESS FOR THE PRODUCTION OF AN ALKYL HYDROPEROXIDE - A method for preparing an alkyl hydroperoxide obtained by the oxidation of a saturated hydrocarbon using oxygen, preferably of a saturated cyclic hydrocarbon, is described. Also described, is a method for preparing cyclohexyl hydroperoxide by oxidizing cyclohexane with molecular oxygen or a gas containing molecular oxygen preferably in the absence of a catalyst.	02-21-2013

Françoise Jun, Huningue FR

Patent application number	Description	Published
20140287986	TEMPLATE-FIXED PEPTIDOMIMETICS AS INHIBITORS OF FPR1 - Novel template-fixed β-hairpin peptidomimetics of the general formula (I): cyclo[P	09-25-2014

Françoise Khuong-Huu, Paris FR

Patent application number	Description	Published
20120040930	TETRACYCLIC TERPENE SERIES COMPOUNDS, METHODS FOR PREPARING SAME, USES THEREOF AS MEDICINES AND PHARMACEUTICAL COMPOUNDS CONTAINING SAME - The invention concerns a triterpene alkaloid of general formula (I). The invention also concerns a method for making same and use thereof as medicine.	02-16-2012

Françoise Lavialle, Antony FR

Patent application number	Description	Published
20100178702	EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba	07-15-2010

Françoise Lavialle, Antony FR

Patent application number	Description	Published
20100178702	EXTRACELLULAR VESICLES FROM NON-PATHOGENIC AMOEBAE USEFUL AS VEHICLE FOR TRANSFERRING A MOLECULE OF INTEREST TO AN EUKARYOTIC CELL - The invention relates to membrane vesicles from non-pathogenic amoeba, in particular from the amoeba	07-15-2010

Françoise Megret, Paris FR

Patent application number	Description	Published
20120009216	EARLY DETECTION OF FLAVIVIRUSES USING THE NS1 GLYCOPROTEIN - The invention concerns a method for early detection of a flavivirus-induced infection, comprising the detection of the flavivirus non-structural glycoprotein NS1 in a biological sample during the clinical phase of the infection, by an immunological method using at least two identical or different antibodies, the first antibody consisting of polyclonal or monoclonal antibodies pre-selected for their high affinity for said NS1 protein hexameric in shape.	01-12-2012

Françoise Mille-Rey, Saint Jean De Moirans FR

Patent application number	Description	Published
20140310718	METHOD, COMPUTER PROGRAM AND DEVICE FOR ALLOCATING COMPUTER RESOURCES OF A CLUSTER FOR EXECUTING A TASK SUBMITTED TO SAID CLUSTER - A method and device for allocating computer resources of a cluster for carrying out at least one job controlled by the cluster is disclosed. In one aspect, the method includes determining the placement of the job from physical features of the job and from physical features and availability of the computer resources of at least one processing area of the cluster. The method further includes receiving energy state features of the computer resources of at least the processing area; determining a recommended placement of the at least one job by correlating the physical features of the job, the physical features, availability and energy state of the computer resources on the basis of predetermined rules; and deducing, from the predetermined recommended placement, a recommended allocation list of the computer resources for carrying out the job in the cluster.	10-16-2014

Françoise Pataut, Paris FR

Patent application number	Description	Published
20090053150	Aerosol device containing at least one amps polymer and at least one fixing polymer - The invention concerns a composition packaged in an aerosol container, containing (c) at least a propellant and (b) a hair-styling composition including at least (i) one non polyurethane anionic or nonionic fixing polymer and (ii) at least one polymer comprising at least one ethylenically unsaturated monomer having a sulphonic group, in free form, or partly or totally neutralized.	02-26-2009
20100202997	Cosmetic Composition for the Hair with a Waxy Effect, in Aerosol Form - The disclosure relates to a cosmetic composition for the hair, packaged in an aerosol device, comprising polyols in high concentration together with anionic fixing polymers. It further relates to a cosmetic method for the hair comprising the application of this composition to the hair, and to its use for imparting a waxy effect to the hair.	08-12-2010
20140366905	PROCESS FOR TREATING KERATIN FIBERS - The present invention relates to a process for treating keratin fibers, preferably hair, comprising the steps of: (i) applying to the keratin fibers a reducing composition comprising at least one disulfide and at least one thiol, wherein the weight ratio of disulfide/thiol is from 0.35 to 0.75, inclusive, preferably 0.4 to 0.7, and more preferably 0.45 to 0.65; (ii) optionally rinsing the keratin fibers; (iii) oxidizing the keratin fibers; and (iv) optionally rinsing and/or drying the keratin fibers. The present invention provides a new treatment process, in particular a permanent deformation process, for keratin fibers such as hair, which can provide superior cosmetic effects such as long-lasting deformation, sufficient curl efficiency, reduced hair degradation and non-malodor, in a relatively short period of time.	12-18-2014

Françoise Pataut, Paris FR

Patent application number	Description	Published
20100202997	Cosmetic Composition for the Hair with a Waxy Effect, in Aerosol Form - The disclosure relates to a cosmetic composition for the hair, packaged in an aerosol device, comprising polyols in high concentration together with anionic fixing polymers. It further relates to a cosmetic method for the hair comprising the application of this composition to the hair, and to its use for imparting a waxy effect to the hair.	08-12-2010

Françoise Pellicier, Loury FR

Patent application number	Description	Published
20100233298	COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat.	09-16-2010
20100316745	Use of a cereal extract as a slimming active agent in a slimming cosmetic composition - A cereal extract is cosmetically used and obtained by at least one polar solvent. This cereal extract is used as a slimming agent in a slimming cosmetic composition. The cosmetic use makes it possible to achieve an effective slimming cosmetic care with a natural, nontoxic slimming agent.	12-16-2010
20110091588	ORCHID VANDA COERULEA AS A COSMETIC ACTIVE AGENT - An extract of the orchid	04-21-2011

Françoise Pellicier, Loury FR

Patent application number	Description	Published
20100233298	COSMETIC USE OF PHYTOSPHINGOSINE AS SLIMMING AGENT AND COSMETIC COMPOSITIONS COMPRISING PHYTOSPHINGOSINE - The invention relates to novel cosmetic uses of phytosphingosine or of one of its cosmetically acceptable salts, particularly its hydrochloride, as a slimming agent and/or as an active agent which stimulates the synthesis of leptin by adipocytes, for preparing a cosmetic composition intended for reducing subcutaneous excess fat.	09-16-2010
20100316745	Use of a cereal extract as a slimming active agent in a slimming cosmetic composition - A cereal extract is cosmetically used and obtained by at least one polar solvent. This cereal extract is used as a slimming agent in a slimming cosmetic composition. The cosmetic use makes it possible to achieve an effective slimming cosmetic care with a natural, nontoxic slimming agent.	12-16-2010
20110091588	ORCHID VANDA COERULEA AS A COSMETIC ACTIVE AGENT - An extract of the orchid	04-21-2011

Françoise Perron-Sierra, Paris FR

Patent application number	Description	Published
20150175623	THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Compounds of formula (I):	06-25-2015

Françoise Poulat, Evian-Les-Bains FR

Patent application number	Description	Published
20150336320	METHOD OF MAKING A BOTTLE MADE OF FDCA AND DIOL MONOMERS AND APPARATUS FOR IMPLEMENTING SUCH METHOD - A method of making a bottle (	11-26-2015

Françoise Pratbernou, Antony FR

Patent application number	Description	Published
20140017383	SHELF-STABLE FOOD PRODUCTS AND METHODS OF MAKING SAME - The present disclosure relates to packaged long shelf life edible products, in particular dairy products, comprising tamarind extract, neb neb extract and weak organic acids. These packaged long shelf life edible products can be stored during at least 12 months under conditions of high temperature and high humidity level. The present disclosure also describes the manufacturing process for making the same.	01-16-2014

Françoise Rakotondramanga, Schweighouse Sur Moder FR

Patent application number	Description	Published
20130137188	METHOD OF DETECTING RUPTURE OF MEMBRANES - The present invention relates to a method of detecting rupture of fetal membranes and to a device for implementing said method. In particular, a method of in-vitro detection of a rupture of fetal membranes comprising a step of simultaneously searching, within a specimen of vaginal or cervical secretions, for the alpha fetal protein (AFP) and for the insulinomimetic growth factor-binding protein 1 (IGFBP-1). The present invention finds, in particular, an application in the medical field, especially in the obstetric field.	05-30-2013

Françoise Rakotondramanga, Schweighouse Sur Moder FR

Patent application number	Description	Published
20130137188	METHOD OF DETECTING RUPTURE OF MEMBRANES - The present invention relates to a method of detecting rupture of fetal membranes and to a device for implementing said method. In particular, a method of in-vitro detection of a rupture of fetal membranes comprising a step of simultaneously searching, within a specimen of vaginal or cervical secretions, for the alpha fetal protein (AFP) and for the insulinomimetic growth factor-binding protein 1 (IGFBP-1). The present invention finds, in particular, an application in the medical field, especially in the obstetric field.	05-30-2013

Françoise Rohner-Jeanrenaud, Thonex CH

Patent application number	Description	Published
20130085100	New Uses of Oxytocin-Like Molecules and Related Methods - The present invention is directed to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful for the treatment of a disorder selected from obesity and insulin resistance and related methods and pharmaceutical formulations. In particular, the invention relates to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful in the treatment of metabolic syndrome.	04-04-2013

Françoise Rohner-Jeanrenaud, Thonex CH

Patent application number	Description	Published
20130085100	New Uses of Oxytocin-Like Molecules and Related Methods - The present invention is directed to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful for the treatment of a disorder selected from obesity and insulin resistance and related methods and pharmaceutical formulations. In particular, the invention relates to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful in the treatment of metabolic syndrome.	04-04-2013

Françoise Sailhan, Paris FR

Patent application number	Description	Published
20100020721	Arrangement and Method Relating to Routing of IP Traffic in Mobile Wireless Newtorks - The present invention relates to a proactive optimized link state protocol and a node with routing means supporting such a protocol implementing multipoint relaying for distribution of control messages, e.g. comprising hello messages, which are extended and comprise neighbour information, link status information and resource related information, and second control messages, e.g. TC messages comprising information relating to MPR selectors which are extended to also hold information of a shared information repository (	01-28-2010
20100278184	Method of Processing Event Notifications and Event Subscriptions - A method of processing event subscriptions in a telecommunications or data network comprising a plurality of nodes organized in clusters, in multiple layers. Each cluster has a cluster leader. The method comprises maintaining by each node a routing table comprising a list of nodes in its cluster and a repository of event subscriptions; forwarding an ascending subscription by a node to all nodes within its cluster and to its cluster's leader; forwarding a descending subscription to all nodes of all layers that the node is a leader and adding a received event subscription to the event subscriptions repository and associating said subscription with a node, which forwarded it.	11-04-2010
20110188378	Arrangement and Method Relating to Network Management - The present invention relates to a network management system for management of a traffic network comprising a wired as well as a wireless network backbone. The wireless network backbone comprises relay nodes comprising wireless routers, some acting as gateways to the wired backbone network and some as relay bridge routers for access network access. The management system comprises a logical multilevel hierarchical network overlying the traffic network. It is adapted to use the infrastructure of the traffic network by using the relay nodes as management stations. It comprises grouping means adapted to perform a grouping process by arranging network nodes, comprising the relay nodes, in groups, each with selected a cluster head, on different hierarchical levels. Grouping control means are provided to control the grouping and allocation of cluster heads based on a number of grouping constraints given by one or more criteria to be fulfilled at each hierarchical level. Calculating means are adapted to calculate the criteria based on given metrics and modeling and verification means are provided for modeling the constraints and verifying fulfillment of said constraints at each hierarchical level.	08-04-2011
20110191460	System and a Method Relating to Network Management - The present invention relates to a node supporting networking and communication with other nodes by means of a layered communication protocol and group communication with other nodes controlled via a grouping protocol adapted to interact with said communication protocol. The node comprises a policy engine which is arranged separately from, but in communication with said grouping protocol. The policy engine is adapted to establish current and/or changing node, group and network related information and to use one or more grouping policies to automatically and dynamically control grouping related actions and adapt the grouping. The invention also relates to a system comprising a number of such nodes and a method of controlling grouping.	08-04-2011

Françoise Sailhan, Paris FR

Patent application number	Description	Published
20100278184	Method of Processing Event Notifications and Event Subscriptions - A method of processing event subscriptions in a telecommunications or data network comprising a plurality of nodes organized in clusters, in multiple layers. Each cluster has a cluster leader. The method comprises maintaining by each node a routing table comprising a list of nodes in its cluster and a repository of event subscriptions; forwarding an ascending subscription by a node to all nodes within its cluster and to its cluster's leader; forwarding a descending subscription to all nodes of all layers that the node is a leader and adding a received event subscription to the event subscriptions repository and associating said subscription with a node, which forwarded it.	11-04-2010

Françoise Schmutz, Givry FR

Patent application number	Description	Published
20100078277	Valve Assembly for Damper between a Lower Chamber and a Compensation Chamber in the Damper - A valve assembly is provided. The valve assembly includes a valve sliding in a valve holder and a base. The valve holder is held by the base by a resilient holding mechanism, the valve holder is mobile with respect to the base between a compression position and an expansion position. The valve holder includes a seat and a body extending beneath the seat and extending into the base. The holding mechanism is fixed on the one hand to the body of the valve holder and includes at least one portion extending beneath the lower face of the base, the portion resting against the lower face when the valve holder is in the expansion position. A damper is also provided.	04-01-2010

Françoise Soulie-Fogelman, Paris FR

Patent application number	Description	Published
20130124448	METHOD AND SYSTEM FOR SELECTING A TARGET WITH RESPECT TO A BEHAVIOR IN A POPULATION OF COMMUNICATING ENTITIES - The method uses predictive analysis to determine a model based on past data including a first social network built between communicating entities for a first observation period and behavioral centrality measures derived from behavioral data observed in a following time period. The model thus determined is then applied to a second social network built for a second observation period more recent than the first one. This provides predicted behavioral centrality measures for a future period, which can be used to perform an efficient selection of entities in the target, which may maximize virality with respect to the specific behavior of interest.	05-16-2013

Françoise Soulie-Fogelman, Paris FR

Patent application number	Description	Published
20130124448	METHOD AND SYSTEM FOR SELECTING A TARGET WITH RESPECT TO A BEHAVIOR IN A POPULATION OF COMMUNICATING ENTITIES - The method uses predictive analysis to determine a model based on past data including a first social network built between communicating entities for a first observation period and behavioral centrality measures derived from behavioral data observed in a following time period. The model thus determined is then applied to a second social network built for a second observation period more recent than the first one. This provides predicted behavioral centrality measures for a future period, which can be used to perform an efficient selection of entities in the target, which may maximize virality with respect to the specific behavior of interest.	05-16-2013

Françoise Villée, Ville-Pommeroeul BE

Patent application number	Description	Published
20120190031	MARKER FOR DIAGNOSIS OF ACTIVE MULTIPLE SCLEROSIS - The invention provides an improved method for monitoring the course of the MS disease and to predict, diagnose or prognosticate whether a subject is in an active or non-active period of MS. The method is based on determining the ratio of the expression levels of two cytokines, measured before and after stimulation of the subject by an immunomodulator.	07-26-2012